Effect of fenofibrate on plasma level of BDNF and brain oxidative stress markers in pentylenetetrazole-induced kindling seizure in mice

AuthorNahid Sarahianen
AuthorMohammad Taghi Mohammadien
AuthorShima Shahyaden
AuthorMohsen Rezaeien
OrcidShima Shahyad [0000-0002-5483-5367]en
Issued Date2021-10-31en
AbstractIntroduction: The neuroprotective effect and pleiotropic functions of PPARα agonists (peroxisome proliferator activated receptor-alpha) such as fenofibrate and bezafibrate have been demonstrated by the previous studies. The current study evaluated the antiepileptic effects and neuroprotective functions of fenofibrate in pentylenetetrazole (PTZ)-induced kindling seizure in mice. Materials and Methods: Adult male NMRI mice were randomly assigned into three groups (n=8): Control, untreated kindled mice and fenofibrate-treated kindled animals. Repeated intraperitoneal injections of PTZ (45 mg/kg) once every 48 hours were used to develop the kindling seizure for 21 days. Treated mice were administered orally fenofibrate at doses of 30 mg/kg/day. Plasma level of brain-derived neurotrophic factor (BDNF), brain level of malondialdehyde (MDA) and histopathological changes were evaluated at termination of the study. Results: Fenofibrate administration considerably improved the seizure latency in treated kindled mice. Fenofibrate significantly (Pen
DOIhttps://doi.org/en
KeywordFenofibrateen
KeywordStatus epilepticusen
KeywordNeuroprotectionen
KeywordBrain-Derived Neurotrophic Factoren
KeywordMalondialdehydeen
Keywordفنوفیبراتen
Keywordصرع مستمرen
Keywordمحافظت عصبیen
Keywordفاکتور نوروتروفیک مشتق شده مغزیen
Keywordمالون‌دی‌آلدهیدen
PublisherBrieflandsen
TitleEffect of fenofibrate on plasma level of BDNF and brain oxidative stress markers in pentylenetetrazole-induced kindling seizure in miceen
TypeResearch Articleen

Files

Collections